ketek and Disopyramide extended release Interactions

Printable Version   Email to a friend

You searched for interactions between

  • ketek (telithromycin)
  • Disopyramide extended release (disopyramide)

Interaction(s) found:

Major Drug-Drug Interaction disopyramide and telithromycin (Major Drug-Drug)

GENERALLY AVOID: Telithromycin has the potential to prolong the QT interval of the electrocardiogram in some patients. Theoretically, coadministration with other agents that can prolong the QT interval may result in elevated risk of ventricular arrhythmias, including ventricular tachycardia and torsade de pointes, because of additive arrhythmogenic potential related to their effects on cardiac conduction.

MANAGEMENT: Telithromycin should be avoided in patients treated with class IA (e.g., disopyramide, quinidine, procainamide) or class III (e.g., amiodarone, dofetilide, sotalol) antiarrhythmic agents.


MedNotes
Advertisement